KBI Global Investors’s West Pharmaceutical WST Stock Holding History

KBI Global Investors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.33M	Buy	+30,760	New	+$2.24M	0.06%	115

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

KBI Global Investors's WST Position: Q2 2016 in Review

KBI Global Investors opened a new position in West Pharmaceutical (WST) in Q2 2016: 30,760 shares worth $2.33M. The stake represents 0.06% of the portfolio and ranks #115 among its holdings.

289 funds tracked by Wall St. Rank hold WST as of Q2 2016.

KBI Global Investors held 30,760 shares of West Pharmaceutical worth $2.33M as of Q2 2016.
West Pharmaceutical was a new KBI Global Investors position in Q2 2016.
West Pharmaceutical made up 0.06% of KBI Global Investors's portfolio in Q2 2016, its #115 holding.
289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2016.

Based on KBI Global Investors's 13F filing for Q2 2016, filed 3 Aug 2016.